$ALST Pulls Back to Key Trend Support on RSI Signal$ALST shares have pulled back to key price level support, with another RSI bull signal in play.
The company is a core play on the continued need for PPE and virus testing, which will remain a major theme for the foreseeable future as new variants of the virus keep finding their way into the headlines.
AllStar Health Brands Inc (OTCMKTS:ALST) is an increasingly interesting story. A specialty pharmaceutical and nutritional supplements company focusing on personal protection equipment and the development of a mobile virus testing lab in partnership with TPT Global Tech, a technology and solutions company, ALST has recently made strides to position itself as an emerging player in the post-pandemic virus prevention space.
One of the most important ideas gradually breaking through public consciousness is the notion that we are never going to truly be rid of Covid-19.
This is a marathon, not a sprint. Covid-19 will keep popping back up like whack-a-mole, seasonally re-sprouting in an emerging market and then appearing in Tacoma or Peoria or Boston in a shopping mall. The point is this: our best path forward will be persistent awareness and preventative protocols and practices.
As the Wall Street Journal recently put it: Covid-19 is going to be a billion-dollar business for years to come.
ALST is a company aligned to capitalize on that theme and provide value in the process. And the company’s latest communications expand on that premise in meaningful ways. In addition, recent communications also align the company to some extent with the cannabis craze given its association with CBD products.
ALST trade ideas
$ALST Breaks Out from Classic Cup-With-Handle BaseAllstar Health Brands Inc (OTCMKTS:ALST) is a micro-cap antibody testing play.
We talked about this one a few days ago as "a chart sporting a classic Cup W/ Handle basing pattern as the need for testing services begins to cement itself as a long-term endemic economic issue."
That pattern triggered as the stock jumps on expansion into the South African virus testing market. In this juiced market environment, the upside potential here continues to be ripe with possibilities.
$ALST Cup-w-Handle Bull Base Builds on L-T Testing ThesisAllstar Health Brands Inc (OTCMKTS:ALST) is a micro-cap antibody testing play with a chart sporting a classic Cup W/ Handle basing pattern as the need for testing services begins to cement itself as a long-term endemic economic issue.
The Company is a specialty pharmaceutical and nutritional supplements company. One of its core assets at this point is its partnership with TPT Global Tech, a technology and solutions company. The two companies are collaborating to create and distribute the QuickLAB module, a rapid testing solution for Covid-19.
The two companies had already recently signed an agreement for Mexico and other Latin American countries through TPT Global Tech's partner New Orbit Technologies. Now, they have signed an expanded agreement to bring QuickLAB distribution to Canada and US to add to the existing Non-Exclusive Distribution Agreement for Mexico and other Latin American countries.
Allstar Health Brands Inc (OTCMKTS:ALST) most recently announced it has signed an Agreement with a Consulting group intending to Distribute the COVID-19 suite of testing capabilities and reporting Software AllStar Distributes for TPT Medtech. The new territories include South Africa, Sub-Saharan Africa, Angola and Portugal.
"Our goal is to quickly build on the model we have begun in Jamaica, and now offer rapid and reliable testing solutions to various sectors of the South African economy, including testing in the vast mining industry as well as other sectors of the economy such as tourism and the public in general," remarked Dr. Daniel Bagi, CEO of AllStar. "We offer a full range of solutions, including the mobile testing labs which can be set-up at the entrance to mines, complete with all the current testing solutions available: PCR, Antigen, and Antibody tests as well as the QuikPASS and Check & Verify software to ensure the testing is validated across several accepted platforms. The added benefit of the software is that once vaccinations begin, the results will also be available on the individual's ‘COVID19 passport’. We view acceptance and launch in South Africa as a springboard into other countries in Africa, so we are working towards having South Africa as our entry point into the Continent.”
Allstar Health Brands Inc (OTCMKTS:ALST) generated sales of $178K, according to information released in the company's most recent quarterly financial report. That adds up to a sequential quarter-over-quarter growth rate of 224.2% on the top line. ALST is surely a more speculative name on this list. But with the company’s recent expansion and partnership, it may also be the most underpriced.
$ALST Holds Support, Eyes Targets to the UpsideALST shares are holding double-bottom base support in recent action, with a range target at the recent highs in confluence with the 50-day SMA around $0.20. A breakout above this level would be a big signal.
This is a Covid testing play, and cold and flu season looms large.
$ALST Holds Key Support on Testing Partnership before 2nd WaveALST is a micro-cap antibody testing play that recently signed a partnership to deliver a mobile testing lab service to high-traffic areas.
The stock recently made a lower low on the chart, but after breaking its downtrend line. MACD shows a bull divergence in place, and shares just held support and may have formed a key base in front of a virus second wave as we approach the onset of cold and flu season.
$ALST Holds Support, Expands Virus Testing Mobile Lab BizALST frames itself as a specialty pharmaceutical and nutritional supplements company. One of its core assets at this point is its partnership with TPT Global Tech, a technology and solutions company. The two companies are collaborating to create and distribute the QuickLAB module, a rapid testing solution for Covid-19.
Testing is going to be a huge facet of any solution that can head off the Twindemic disaster that experts believe looms over the coming fall and winter.
The two companies had already recently signed an agreement for Mexico and other Latin American countries through TPT Global Tech's partner New Orbit Technologies. Now, as of this week, they have signed an expanded agreement to bring QuickLAB distribution to Canada and US to add to the existing Non-Exclusive Distribution Agreement for Mexico and other Latin American countries.
"We are very pleased to announce the expansion of our initial non-exclusive partnership agreement to now include Canada and the US. AllStar Health Brands' goal is to work with TPT Medtech for both the geographic expansion of the QuikLAB modules within the US and Canada and also offer the best testing technologies within the QuikLAB modules. Both companies have a shared vision to make one-stop, mass testing for Covid-19, a near-term reality in the Americas," stated Dr. Daniel Bagi, President of AllStar.
According to the release, AllStar believes that given the high Covid-19 infection rates around the world, and the ability to set up the QuikLAB testing modules at almost any location, the QuikLAB option may be part of the solution in combating the effects of this pandemic.
The company notes that the QuikLAB testing modules offer a fast, complete testing option, at a rapid throughput, - up to 50 tests/hour, using either the PCR or antibody tests or both currently available on the market. The goal is to provide results within minutes to a few short hours, so appropriate treatment or isolation protocols can be recommended based on the results of the testing.
Since then, the company has gotten increasingly involved in the testing niche. Looking ahead, AllStar says it plans to provide several options for FDA, EUA-approved rapid Covid-19 anti-body tests, and PCR tests for the TPT Medtech QuikLab modules. This could make its QuickLAB module a kind of one-stop-shop solution for communities with less than adequate testing supplies anywhere in the western hemisphere now that its partnership extends through the US and Canada.
$ALST Could have Fireworks Ahead?ALST is a micro-cap antibody testing play that is apparently done going down -- at least, so says the chart. The momo lower has exhausted itself with an RSI living in oversold territory and the pattern now clearly lateral in nature.
The breakout trigger levels are accumulating just overhead.
$ALST Speculative PPE Covid Play With Bullish Pattern PostureALST is thin, but promising from the standpoint of a base of clear support, a broken downtrend line, and a serial RSI divergence sequence following a bullish oversold RSI reading at the initial downside price extreme that started the basing process.
--------------------------
ALST (Allstar Health Brands Inc.) is a Nevada Corporation established in 2017, and headquartered in Miami, Florida.
AllStar is a specialty Health Care Products Company dedicated to improving health and quality of life by offering select products, including medical devices, nutritional supplements, over the counter remedies and medicines across the Americas and Europe. AllStar's goal is to bring additional products to the market and provide new, innovative options for better health and well-being.
The company focuses on enhancing health and quality of life by offering select medicines, natural nutritional supplements, and over the counter remedies in the Americas. AllStar holds the “Tapout” brand license to sell globally branded nutraceutical products, including pain relief sprays and wipes. It has partnership with World Wide Entertainment (WWE) to market and sell their line of “Tapout” branded nutraceutical products.
In addition, according to recent materials, the company has begun to focus sharply on front-line products. AllStar is now working with qualified overseas suppliers to provide products such as PPE (Personal Protective Equipment) as demand is expected to increase sharply with the gradual re-opening of the economy.
AllStar has already begun distributing protective masks and is expanding its product line to include gowns and gloves to established businesses and various types of medical clinics such as optometrists, long-term care facilities and hospitals. As such, first-order deliveries of the Covid-19 IgG/IgM antibody rapid test have already been made to a Distributor for the Caribbean and Latin American region, and US delivery is in process. In addition, KN 95 protective masks, - the functional equivalent of the N 95 mask - have been sold already in Canada and AllStar is also working to deliver the much-needed masks to other countries.
Key Points:
• ALST booked a sharp leap in sales in May, with a sudden influx of over $100K in revenues as the company ramps up commercial-stage operations in the Covid-19 space
• ALST is making real money, with trailing revs already coming in, an apparently accelerating as its antibody testing and PPE offerings gain traction
• ALST recently stated that management believes it could see as much as $1 million in sales in 2020.
• ALST is also seeing some basing activity on the chart, with a broken downtrend line now as the salient feature, along with gradually ramping liquidity and trading volume
• ALST just got current with the OTC
• ALST is coming off an RSI trough under 40, pointing to a massively oversold stock now heading back the other way.
Conclusion
ALST just got fully current with OTC markets. This story is just starting to hit the radar for traders and investors searching for opportunities in the PPE and antibody testing space.
The company just booked $100k in sales for COVID-19 products over a month of aggressive activity in May, and there’s no signs of decline so far in June according to the company. Given this activity, and the stock’s action – which shows both positive technical signals in terms of trend as well as increasing trading activity and liquidity – one might reasonably anticipate some coming opportunities as it becomes more visible as a play in the space.
This is a company, by all available information, that is predicated on aggressive sales and marketing efforts. And, as outlined by management in recent communications, it is actively engaged in opening doors to PPE and antibody testing kit sales in South America as the Covid-19 pandemic health crisis erupts in the southern hemisphere during their winter and cold & flu season.